/Investor DB

Jennison Associates — Full Portfolio

2 tracked investments · listed companies and verified rows first

Afferent PharmaceuticalsinJul 2015

BiotechSan Mateo, US

Anthony Ford(Executive Officer)inMichael Kitt(Executive Officer)inKathleen Sereda Glaub(Executive Officer, Director)in

BoardKevin Starr(Director)inArthur Pappas(Director)Liam Ratcliffe(Director)

Co-investorsPappas CapitalDomain AssociatesFidelity InvestmentsThird Rock Ventures

Field Trip Healthfieldtriphealth.comin𝕏Mar 2021

Field Trip Health provides ketamine-assisted therapy for treatment-resistant depression and anxiety, offering rapid symptom relief through clinically monitored ketamine administration combined with psychotherapy.

Digital HealthHealthtechMedical DevicesMental Health

Co-investorsBT Growth CapitalFrontera Technology VenturesEarl Grey CapitalPura Vida InvestmentsSoleus CapitalSphera Funds Management

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.